Authors
- Lea Skorup — Thalassotherapia Crikvenica, Crikvenica, Hrvatska — ORCID: 0000-0003-2246-0908
- Ivana Grgić Romić — Sveučilište u Rijeci, Medicinski fakultet, Klinički bolnički centar Rijeka, Rijeka, Hrvatska — ORCID: 0000-0002-0035-4445
- Nikolina Jurjević — Klinička bolnica Merkur, Zagreb, Hrvatska — ORCID: 0000-0003-2663-6843
- Valentina Obadić — Zavod za hitnu medicinu Primorsko-goranske županije, Rijeka, Hrvatska — ORCID: 0000-0001-9915-5122
- Ana Valković — Klinička bolnica “Sveti Duh” Zagreb, Hrvatska — ORCID: 0000-0001-7503-2259
- Mihaela Paušić — Sveučilište u Splitu, Sveučilišni odjel za forenzične znanosti, Split, Hrvatska — ORCID: 0000-0003-2357-6662
- Alen Ružić — Sveučilište u Rijeci, Medicinski fakultet, Klinički bolnički centar Rijeka, Rijeka, Hrvatska — ORCID: 0000-0001-5031-2975
- Teodora Zaninović Jurjević — Sveučilište u Rijeci, Medicinski fakultet, Klinički bolnički centar Rijeka, Rijeka, Hrvatska — ORCID: 0000-0001-8359-3910
- Luka Zaputović — Sveučilište u Rijeci, Medicinski fakultet, Klinički bolnički centar Rijeka, Rijeka, Hrvatska — ORCID: 0000-0001-9415-9618
Abstract
**Aim**: Present heart failure (HF) patients hospitalized during the period of one year in University Hospital Centre Rijeka, describe their characteristics and hospital outcome according to left ventricular ejection fraction (EF) with emphasis placed on heart failure with mid-range ejection fraction (HFmrEF) and compare our results with literature data (1). **Patients and Methods**: Retrospective, observational study was conducted with a total of 375 subjects. All patients hospitalized for heart failure were included, same sample we introduced to European Society of Cardiology HF Register, except those presented with cardiogenic shock or acute coronary syndrome. Patients were classified in three groups according to their left ventricular ejection fraction (EF ≤40%, EF 40-49%, EF ≥50%) measured using echocardiography. **Results**: In comparison with HFpEF (heart failure with preserved ejection fraction) subjects, patients with HFrEF (heart failure with reduced ejection fraction) were younger (73 vs. 78 years, p<0.01), more commonly male (64% vs 34%, p<0.01) with left bundle branch block (32% vs. 7%, p<0.01) and higher prevalence of ischemic HF etiology (52% vs. 22%, p<0.01). HRpEF patients had hypertension (3% vs 14%) more often as a confirmed cause of HF. As expected, atrial fibrillation was significantly more common in HFpEF group (41% vs. 65%, p<0.01). The HFmrEF category resembled the HFpEF population regarding age, gender, body mass index and atrial fibrillation frequency. The average length of hospitalization (8 days) and the intrahospital mortality (6%) did not differ significantly between groups. **Conclusion**: Despite possible differences between HFmrEF and the other two investigated HF categories, our HFmrEF population predominantly resembled HFpEF group. Unlike HFrEF group characteristics and its management, the other two heart failure categories are globally not sufficiently defined. Hence their future research is of special importance for development of evidence-based medical practice.
Keywords
heart failure, epidemiology, left ventricular ejection fraction
DOI
https://doi.org/10.15836/ccar2018.377Literature
- Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017 Dec;19(12):1574–85. https://doi.org/10.1002/ejhf.813